IP Library Granted Patent US 8,597,692
Granted Patent B2
US 8,597,692 · App. 12/597,550 · Granted Dec 3, 2013

Cocoa extract and use thereof

Inventors: Herwig Bernaert (Lebbeke-Wieze, BE); Leen Allegaert (Lebbeke-Wieze, BE)
Assignee: Barry Callebaut AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,597,692
App. No.
12/597,550
Granted
Dec 3, 2013
Kind
B2
Abstract

A cocoa extract obtainable by the extraction of non-defatted cocoa beans which have not been fermented or have been allowed to ferment for no more than three days, having a polyphenol content of more than 25% by weight, may be used in the treatment or prophylaxis of a condition selected from dysphoria, depression, anxiety, sleep disorders, gastric motility disorders, sexual dysfunction, brain trauma, memory loss, appetite disorders, bulimia, substance abuse, alcoholism, tobacco addiction, obsessive-compulsive disease, panic disorder, premenstrual syndrome, and migraine.

Claims (26)

1. A method for the treatment of dysphoria, comprising administering an effective amount of a cocoa extract to a patient in need thereof, wherein the cocoa extract is obtained by the extraction of non-defatted cocoa nibs obtained from cocoa beans which have not been fermented or have been allowed to ferment for no more than three days, having a polyphenol content of more than 25% by weight.

2. The method of claim 1 , wherein the cocoa extract has a polyphenol content of at least 30% by weight.

3. The method of claim 1 , wherein the cocoa extract has a polyphenol content of from 30 to 70% by weight.

4. The method of claim 1 , wherein the cocoa extract has a theobromine content of at least 5% by weight.

5. The method of claim 1 , wherein the cocoa extract a theobromine content of less than 5% by weight.

6. The method of claim 1 , wherein the dysphoria is not associated with any diagnosed clinical depression or anxiety.

7. The method of claim 1 , wherein the cocoa extract is obtained by solvent extraction of the cocoa nibs.

8. The method of claim 7 , wherein the solvent is selected from C1 to C6 alcohols or ketones, and mixtures thereof, optionally in admixture with water.

9. The method of claim 7 , wherein the solvent is selected from ethanol, acetone, 2-butanol, 2-propanol and mixtures thereof, optionally in admixture with water.

10. The method of claim 1 , wherein the cocoa extract comprises less than 2% by weight phenylethylamine.

11. The method of claim 1 , wherein the cocoa extract comprises from 0.1 to 10% by weight of cocoa fats.

12. The method of claim 11 , wherein the cocoa extract comprises from 0.2 to 5% by weight of cocoa fats.

13. The method of claim 11 , wherein the cocoa fats are non-triglyceride lipids.

14. The method of claim 1 , wherein the cocoa extract comprises:

(i) from 35 to 70% by weight cocoa polyphenols;

(ii) from 1 to 10% by weight xanthines;

(iii) less than 2% by weight phenylethylamine; and

(iv) from 0.1 to 10% by weight of cocoa fats.

15. The method of claim 1 , wherein the cocoa extract comprises from 15 to 40% by weight protein.

16. The method of claim 1 , wherein the cocoa extract comprises from 2 to 12% by weight sugars.

17. The method of claim 1 , wherein the cocoa extract is provided as part of a food or confectionery product.

18. The method of claim 1 , wherein the cocoa extract is provided as a pharmaceutical composition or supplement.

19. A method for the treatment of dysphoria, comprising administering a composition comprising an effective amount of a cocoa extract to a patient in need thereof, wherein the cocoa extract is obtained by the extraction of non-defatted cocoa beans which have not been fermented or have been allowed to ferment for not more than three days, having a polyphenol content of more than 25% by weight, wherein the composition does not comprise a dopamine D2 receptor agonist.

20. A method for the treatment of dysphoria, comprising orally administering an effective amount of a cocoa extract to a patient in need thereof, wherein the cocoa extract is obtained by the extraction of non-defatted cocoa beans with a mixture of acetone and water in a weight ratio of water:acetone of from 1:1 to 1:9 which have not been fermented or have been allowed to ferment for not more than three days, having a polyphenol content of more than 25% by weight.

21. The method of claim 1 , wherein the cocoa extract is spray-dried.

22. A method of claim 21 wherein the spray-dried cocoa extract is agglomerated in a fluidized bed.

Assignments (2)
CHANGE OF ADDRESS Recorded Apr 21, 2023
From: BARRY CALLEBAUT AG
To: BARRY CALLEBAUT AG
Reel/Frame 063635/0291 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2010
From: BERNAERT, HERWIG; ALLEGAERT, LEEN
To: BARRY CALLEBAUT AG
Reel/Frame 024175/0126 →
Priority Claims (1)
GB 0719544.9 · Oct 8, 2007 · national
Continuity (2)
Provisional Application 60926328 · Apr 26, 2007
Related Publication 20100189829A1 · Jul 29, 2010